Inhibition of the PI3K/AKT pathway leads to decreased cell proliferation in chronic lymphoblastic leukemia (CLL) [13] and acute myeloid leukemia (AML) [14,15]. The gene discussed is PIK3CA; the disease is B-cell chronic lymphocytic leukemia.